Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Fagan

Showing results (181-190 of 279) with videos related to

Pageof 28
Sort By:
Elife|January 6, 2023
Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational studyPeter R Millar, Brian A Gordon, Patrick H Luckett, et al.
Biological Psychiatry|November 2, 2010
YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's diseaseRebecca Craig-Schapiro, Richard J Perrin, Catherine M Roe, et al.
Neurology. Genetics|April 22, 2021
African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic VariantsSuzanne E Schindler, Carlos Cruchaga, Amulya Joseph, et al.
Science Translational Medicine|November 16, 2022
APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expressionAylin Dincer, Charles D Chen, Nicole S McKay, et al.
Plos Genetics|October 24, 2014
Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammationJohn S K Kauwe, Matthew H Bailey, Perry G Ridge, et al.
JAMA Neurology|July 7, 2015
Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle AgeCourtney L Sutphen, Mateusz S Jasielec, Aarti R Shah, et al.
BMC Neurology|November 12, 2016
Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40Yuetiva Deming, Kathleen Black, David Carrell, et al.
Plos Genetics|September 24, 2010
SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's diseaseCarlos Cruchaga, John S K Kauwe, Kevin Mayo, et al.
Neurology|December 29, 2017
Associations between [<sup>18</sup>F]AV1451 tau PET and CSF measures of tau pathology in a clinical sampleRenaud La Joie, Alexandre Bejanin, Anne M Fagan, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 27, 2020
Relationships between big-five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's diseaseAndrew J Aschenbrenner, Jennifer Petros, Eric McDade, et al.
Pageof 28

Showing results (181-190 of 279) with videos related to

Sort By:
Pageof 28
Elife|January 6, 2023
Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational studyPeter R Millar, Brian A Gordon, Patrick H Luckett, et al.
Biological Psychiatry|November 2, 2010
YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's diseaseRebecca Craig-Schapiro, Richard J Perrin, Catherine M Roe, et al.
Neurology. Genetics|April 22, 2021
African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic VariantsSuzanne E Schindler, Carlos Cruchaga, Amulya Joseph, et al.
Science Translational Medicine|November 16, 2022
APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expressionAylin Dincer, Charles D Chen, Nicole S McKay, et al.
Plos Genetics|October 24, 2014
Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammationJohn S K Kauwe, Matthew H Bailey, Perry G Ridge, et al.
JAMA Neurology|July 7, 2015
Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle AgeCourtney L Sutphen, Mateusz S Jasielec, Aarti R Shah, et al.
BMC Neurology|November 12, 2016
Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40Yuetiva Deming, Kathleen Black, David Carrell, et al.
Plos Genetics|September 24, 2010
SNPs associated with cerebrospinal fluid phospho-tau levels influence rate of decline in Alzheimer's diseaseCarlos Cruchaga, John S K Kauwe, Kevin Mayo, et al.
Neurology|December 29, 2017
Associations between [<sup>18</sup>F]AV1451 tau PET and CSF measures of tau pathology in a clinical sampleRenaud La Joie, Alexandre Bejanin, Anne M Fagan, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 27, 2020
Relationships between big-five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's diseaseAndrew J Aschenbrenner, Jennifer Petros, Eric McDade, et al.
Pageof 28